{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:02:36Z","timestamp":1781002956154,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07084-8","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T16:20:50Z","timestamp":1737476450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["RAB3GAP2 dysregulation in adult T-cell leukemia\/lymphoma (ATLL) compared to acute lymphoblastic leukemia (ALL): a molecular perspective"],"prefix":"10.1186","volume":"18","author":[{"given":"Samira","family":"Pourrezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Letafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazale","family":"Molaverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"issue":"6","key":"7084_CR1","first-page":"485","volume":"32","author":"E Eusebio-Ponce","year":"2019","unstructured":"Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ. HTLV-1 infection: an emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Revista Espa\u00f1ola De Quimioterapia. 2019;32(6):485.","journal-title":"Revista Espa\u00f1ola De Quimioterapia"},{"issue":"7","key":"7084_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/jmv.24448","volume":"88","author":"H Rafatpanah","year":"2016","unstructured":"Rafatpanah H, Torkamani M, Valizadeh N, Vakili R, Meshkani B, Khademi H, et al. Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran. J Med Virol. 2016;88(7):1247\u201353.","journal-title":"J Med Virol"},{"issue":"6","key":"7084_CR3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/bloodadvances.2019001429","volume":"4","author":"CLH Guerrero","year":"2020","unstructured":"Guerrero CLH, Yamashita Y, Miyara M, Imaizumi N, Kato M, Sakihama S, et al. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL. Blood Adv. 2020;4(6):1062\u201371.","journal-title":"Blood Adv"},{"key":"7084_CR4","doi-asserted-by":"publisher","first-page":"107513","DOI":"10.1016\/j.carpath.2022.107513","volume":"64","author":"C Aguilar","year":"2023","unstructured":"Aguilar C, Beltran BE, Morales D, Guti\u00e9rrez-Garibay M, Villela L, Marques-Piubelli ML, et al. Isolated cardiac valve involvement in smoldering adult T-cell leukemia\/lymphoma. Cardiovasc Pathol. 2023;64:107513.","journal-title":"Cardiovasc Pathol"},{"issue":"7","key":"7084_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pathogens9070543","volume":"9","author":"S Mohanty","year":"2020","unstructured":"Mohanty S, Harhaj EW. Mechanisms of oncogenesis by HTLV-1 tax. Pathogens. 2020;9(7):543.","journal-title":"Pathogens"},{"issue":"4","key":"7084_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/pathogens8040290","volume":"8","author":"S Fochi","year":"2019","unstructured":"Fochi S, Ciminale V, Trabetti E, Bertazzoni U, D\u2019Agostino DM, Zipeto D, Romanelli MG. NF-\u03baB and microRNA deregulation mediated by HTLV-1 tax and HBZ. Pathogens. 2019;8(4):290.","journal-title":"Pathogens"},{"issue":"12","key":"7084_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.tcb.2016.06.005","volume":"26","author":"J Chu","year":"2016","unstructured":"Chu J, Cargnello M, Topisirovic I, Pelletier J. Translation initiation factors: reprogramming protein synthesis in cancer. Trends Cell Biol. 2016;26(12):918\u201333.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"7084_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-020-0511-0","volume":"17","author":"M Matsuoka","year":"2020","unstructured":"Matsuoka M, Mesnard J-M. HTLV-1 bZIP factor: the key viral gene for pathogenesis. Retrovirology. 2020;17(1):1\u20138.","journal-title":"Retrovirology"},{"issue":"17","key":"7084_CR9","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1101\/gad.266593.115","volume":"29","author":"X Xue","year":"2015","unstructured":"Xue X, Sung P, Zhao X. Functions and regulation of the multitasking FANCM family of DNA motor proteins. Genes Dev. 2015;29(17):1777\u201388.","journal-title":"Genes Dev"},{"key":"7084_CR10","doi-asserted-by":"publisher","first-page":"698190","DOI":"10.3389\/fcell.2021.698190","volume":"9","author":"MC Jaskolka","year":"2021","unstructured":"Jaskolka MC, Winkley SR, Kane PM. RAVE and Rabconnectin-3 complexes as signal dependent regulators of organelle acidification. Front Cell Dev Biology. 2021;9:698190.","journal-title":"Front Cell Dev Biology"},{"issue":"4","key":"7084_CR11","doi-asserted-by":"publisher","first-page":"a006098","DOI":"10.1101\/cshperspect.a006098","volume":"5","author":"R Sever","year":"2015","unstructured":"Sever R, Brugge JS. Signal transduction in cancer. Cold Spring Harbor Perspect Med. 2015;5(4):a006098.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"7084_CR12","doi-asserted-by":"publisher","first-page":"e1009220","DOI":"10.1371\/journal.ppat.1009220","volume":"17","author":"H Feng","year":"2021","unstructured":"Feng H, Zhang Y-B, Gui J-F, Lemon SM, Yamane D. Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses. PLoS Pathog. 2021;17(1):e1009220.","journal-title":"PLoS Pathog"},{"key":"7084_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513\u201345.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"7084_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/febs.13896","volume":"284","author":"K Kashiwagi","year":"2017","unstructured":"Kashiwagi K, Ito T, Yokoyama S. Crystal structure of eIF 2B and insights into eIF 2\u2013eIF 2B interactions. FEBS J. 2017;284(6):868\u201374.","journal-title":"FEBS J"},{"issue":"4","key":"7084_CR15","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/ijms20040961","volume":"20","author":"P Limonta","year":"2019","unstructured":"Limonta P, Moretti RM, Marzagalli M, Fontana F, Raimondi M, Montagnani Marelli M. Role of endoplasmic reticulum stress in the anticancer activity of natural compounds. Int J Mol Sci. 2019;20(4):961.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7084_CR16","first-page":"336","volume":"7","author":"R Mahieux","year":"2003","unstructured":"Mahieux R, Gessain A. HTLV-1 and associated adult T-cell leukemia\/lymphoma. Rev Clin Exp Hematol. 2003;7(4):336\u201361.","journal-title":"Rev Clin Exp Hematol"},{"issue":"24","key":"7084_CR17","doi-asserted-by":"publisher","first-page":"13389","DOI":"10.1128\/JVI.77.24.13389-13395.2003","volume":"77","author":"X Feng","year":"2003","unstructured":"Feng X, Vander Heyden N, Ratner L. AlphaInterferon inhibits human T-Cell leukemia virus type 1 Assembly byPreventing Gag Interaction withRafts. J Virol. 2003;77(24):13389\u201395.","journal-title":"J Virol"},{"issue":"2","key":"7084_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.virol.2008.06.035","volume":"379","author":"J Zhang","year":"2008","unstructured":"Zhang J, Yamada O, Kawagishi K, Araki H, Yamaoka S, Hattori T, Shimotohno K. Human T-cell leukemia virus type 1 tax modulates interferon-\u03b1 signal transduction through competitive usage of the coactivator CBP\/p300. Virology. 2008;379(2):306\u201313.","journal-title":"Virology"},{"issue":"11","key":"7084_CR19","doi-asserted-by":"publisher","first-page":"e1001177","DOI":"10.1371\/journal.ppat.1001177","volume":"6","author":"S Oliere","year":"2010","unstructured":"Oliere S, Hernandez E, Lezin A, Arguello M, Douville R, Nguyen TL-A, et al. HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1). PLoS Pathog. 2010;6(11):e1001177.","journal-title":"PLoS Pathog"},{"issue":"1","key":"7084_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.201901-0214OC","volume":"201","author":"A Watson","year":"2020","unstructured":"Watson A, Spalluto CM, McCrae C, Cellura D, Burke H, Cunoosamy D, et al. Dynamics of IFN-\u03b2 responses during respiratory viral infection. Insights for therapeutic strategies. Am J Respir Crit Care Med. 2020;201(1):83\u201394.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"7084_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2008.05.052","volume":"134","author":"E Apostolou","year":"2008","unstructured":"Apostolou E, Thanos D. Virus infection induces NF-\u03baB-dependent interchromosomal associations mediating monoallelic IFN-\u03b2 gene expression. Cell. 2008;134(1):85\u201396.","journal-title":"Cell"},{"issue":"5","key":"7084_CR22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li H-C, Tomaru U, Yao K, Grant CW, et al. Virus-induced dysfunction of CD4\u2009+\u2009CD25\u2009+\u2009T cells in patients with HTLV-I\u2013associated neuroimmunological disease. J Clin Investig. 2005;115(5):1361\u20138.","journal-title":"J Clin Investig"},{"issue":"4","key":"7084_CR23","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1128\/JVI.01718-06","volume":"81","author":"I Koerner","year":"2007","unstructured":"Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P. Protective role of beta interferon in host defense against influenza a virus. J Virol. 2007;81(4):2025\u201330.","journal-title":"J Virol"},{"issue":"2","key":"7084_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1009287518015","volume":"9","author":"AR Ball Jr","year":"2001","unstructured":"Ball AR Jr, Yokomori K. The structural maintenance of chromosomes (SMC) family of proteins in mammals. Chromosome Res. 2001;9(2):85\u201396.","journal-title":"Chromosome Res"},{"issue":"6","key":"7084_CR25","doi-asserted-by":"publisher","first-page":"e02175","DOI":"10.1128\/jvi.02175-21","volume":"96","author":"S Chen","year":"2022","unstructured":"Chen S, Liu Q, Zhang L, Ma J, Xue B, Li H, et al. The role of REC8 in the innate immune response to viral infection. J Virol. 2022;96(6):e02175\u201321.","journal-title":"J Virol"},{"issue":"5","key":"7084_CR26","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1002\/jcb.26546","volume":"119","author":"SH Mozhgani","year":"2018","unstructured":"Mozhgani SH, Zarei-Ghobadi M, Teymoori\u2010Rad M, Mokhtari\u2010Azad T, Mirzaie M, Sheikhi M, et al. Human T\u2010lymphotropic virus 1 (HTLV\u20101) pathogenesis: a systems virology study. J Cell Biochem. 2018;119(5):3968\u201379.","journal-title":"J Cell Biochem"},{"issue":"1","key":"7084_CR27","doi-asserted-by":"publisher","first-page":"e0169648","DOI":"10.1371\/journal.pone.0169648","volume":"12","author":"C Niu","year":"2017","unstructured":"Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, et al. The Smc5\/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection. PLoS ONE. 2017;12(1):e0169648.","journal-title":"PLoS ONE"},{"issue":"10","key":"7084_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/pathogens9100786","volume":"9","author":"RT Gibson","year":"2020","unstructured":"Gibson RT, Androphy EJ. The SMC5\/6 complex represses the replicative program of high-risk human papillomavirus type 31. Pathogens. 2020;9(10):786.","journal-title":"Pathogens"},{"issue":"1","key":"7084_CR29","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.18632\/aging.202455","volume":"13","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wu G, Tong Z, Sun J, Su J, Cao Z, et al. Prognostic relevance of SMC family gene expression in human sarcoma. Aging. 2021;13(1):1473.","journal-title":"Aging"},{"issue":"5","key":"7084_CR30","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.chom.2021.03.001","volume":"29","author":"L Dupont","year":"2021","unstructured":"Dupont L, Bloor S, Williamson JC, Cuesta SM, Shah R, Teixeira-Silva A, et al. The SMC5\/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr. Cell Host Microbe. 2021;29(5):792\u2013805. e6.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"7084_CR31","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1053\/j.gastro.2006.09.007","volume":"131","author":"A Couvelard","year":"2006","unstructured":"Couvelard A, Hu J, Steers G, Dermot OT, Sauvanet A, Belghiti J, et al. Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology. 2006;131(5):1597\u2013610.","journal-title":"Gastroenterology"},{"issue":"1","key":"7084_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0473-1","volume":"36","author":"J Tian","year":"2017","unstructured":"Tian J, Wang Y, Zhang X, Ren Q, Li R, Huang Y, et al. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 signaling. J Experimental Clin Cancer Res. 2017;36(1):1\u201313.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"37","key":"7084_CR33","doi-asserted-by":"publisher","first-page":"39924","DOI":"10.18632\/oncotarget.5442","volume":"6","author":"C Vaysse","year":"2015","unstructured":"Vaysse C, Philippe C, Martineau Y, Quelen C, Hieblot C, Renaud C, et al. Key contribution of eIF4H-mediated translational control in tumor promotion. Oncotarget. 2015;6(37):39924.","journal-title":"Oncotarget"},{"issue":"12","key":"7084_CR34","doi-asserted-by":"publisher","first-page":"7911","DOI":"10.1093\/nar\/gku440","volume":"42","author":"U Harms","year":"2014","unstructured":"Harms U, Andreou AZ, Gubaev A, Klostermeier D. eIF4B, eIF4G and RNA regulate eIF4A activity in translation initiation by modulating the eIF4A conformational cycle. Nucleic Acids Res. 2014;42(12):7911\u201322.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"7084_CR35","doi-asserted-by":"publisher","first-page":"194583","DOI":"10.1016\/j.bbagrm.2020.194583","volume":"1863","author":"A Barrera","year":"2020","unstructured":"Barrera A, Olgu\u00edn V, Vera-Otarola J, L\u00f3pez-Lastra M. Cap-independent translation initiation of the unspliced RNA of retroviruses. Biochim et Biophys Acta (BBA)-Gene Regul Mech. 2020;1863(9):194583.","journal-title":"Biochim et Biophys Acta (BBA)-Gene Regul Mech"},{"issue":"5","key":"7084_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.molcel.2012.12.010","volume":"49","author":"Y Wang","year":"2013","unstructured":"Wang Y, Leung JW, Jiang Y, Lowery MG, Do H, Vasquez KM, et al. FANCM and FAAP24 maintain genome stability via cooperative as well as unique functions. Mol Cell. 2013;49(5):997\u20131009.","journal-title":"Mol Cell"},{"issue":"8","key":"7084_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/pin.12953","volume":"70","author":"G Dzaparidze","year":"2020","unstructured":"Dzaparidze G, Anion E, Laan M, Minajeva A. The decline of FANCM immunohistochemical expression in prostate cancer stroma correlates with the grade group. Pathol Int. 2020;70(8):542\u201350.","journal-title":"Pathol Int"},{"key":"7084_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2019.04.061","volume":"235","author":"JL Lopes","year":"2019","unstructured":"Lopes JL, Chaudhry S, Lopes GS, Levin NK, Tainsky MA, FANCM. RAD1, CHEK1 and TP53I3 act as BRCA-like tumor suppressors and are mutated in hereditary ovarian cancer. Cancer Genet. 2019;235:57\u201364.","journal-title":"Cancer Genet"},{"issue":"1","key":"7084_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10409238.2019.1568963","volume":"54","author":"J Basbous","year":"2019","unstructured":"Basbous J, Constantinou A. A tumor suppressive DNA translocase named FANCM. Crit Rev Biochem Mol Biol. 2019;54(1):27\u201340.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"8","key":"7084_CR40","doi-asserted-by":"publisher","first-page":"110840","DOI":"10.1016\/j.celrep.2022.110840","volume":"39","author":"S Fu","year":"2022","unstructured":"Fu S, Phan AT, Mao D, Wang X, Gao G, Goff SP, Zhu Y. HIV-1 exploits the fanconi anemia pathway for viral DNA integration. Cell Rep. 2022;39(8):110840.","journal-title":"Cell Rep"},{"issue":"10","key":"7084_CR41","first-page":"18123","volume":"8","author":"Y Yang","year":"2015","unstructured":"Yang Y, Liu H, Wang X, Chen L. Up-regulation of microRNA-664 inhibits cell growth and increases cisplatin sensitivity in cervical cancer. Int J Clin Exp Med. 2015;8(10):18123.","journal-title":"Int J Clin Exp Med"},{"key":"7084_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10238-015-0398-6","volume":"17","author":"Y Bao","year":"2017","unstructured":"Bao Y, Chen B, Wu Q, Hu K, Xi X, Zhu W, et al. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7. Clin Experimental Med. 2017;17:51\u20138.","journal-title":"Clin Experimental Med"},{"issue":"4","key":"7084_CR43","first-page":"459","volume":"27","author":"L Wu","year":"2019","unstructured":"Wu L, Li Y, Li J, Ma D. MicroRNA-664 targets insulin receptor substrate 1 to suppress cell proliferation and invasion in breast cancer. Oncol Res Featuring Preclinical Clin Cancer Ther. 2019;27(4):459\u201367.","journal-title":"Oncol Res Featuring Preclinical Clin Cancer Ther"},{"issue":"4","key":"7084_CR44","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1086\/502681","volume":"78","author":"IA Aligianis","year":"2006","unstructured":"Aligianis IA, Morgan NV, Mione M, Johnson CA, Rosser E, Hennekam RC, et al. Mutation in Rab3 GTPase-activating protein (RAB3GAP) noncatalytic subunit in a kindred with Martsolf syndrome. Am J Hum Genet. 2006;78(4):702\u20137.","journal-title":"Am J Hum Genet"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07084-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07084-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07084-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T17:31:31Z","timestamp":1737480691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07084-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7084"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07084-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"informed consent to participate was obtained from all of the participants in the study. In addition, this study was approved at Tehran University of Medical Sciences by the Ethics Committees of Medical Sciences Research (IR.TUMS.SPH.REC.1399.112). This study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}